Previous study has demonstrated that in vitro AMPK activation is a key mediator of the changes in substrate utilization during cardiac ischemia and functions to maintain energy homeostasis, cardiac function and myocardial viability [10]. This evidence concerns the gene PRKAA2 and myocardial ischemia.